Midgard Science

Aarti Pharmalabs Limited

Mumbai, India aartipharmalabs.com From their website, Nov 2026

Work here? Claim this listing

About

Aarti Pharmalabs Limited develops and manufactures APIs, NCEs, HPAPIs, peptides, oligos, payload-linker conjugates, intermediates, and related starting materials for clinical development and commercial production. It serves pharmaceutical and biotechnology customers from sites in Maharashtra and Gujarat, India, with R&D and manufacturing facilities in Nerul, Dombivli, Vapi, Tarapur, and Atali. The company also supplies products for pharmaceutical, nutraceutical, and food/beverages markets and exports to regulated markets worldwide.

Services

  • Small molecules CDMO

    End-to-end contract development and manufacturing services for critical small-molecule drug substances from lab work and pilot scale through clinical trials, launch, and commercial manufacturing.

  • Peptides & oligos (TIDES)

    Development and manufacturing support for peptides and oligonucleotides.

  • Payload-linker conjugates

    Development of payload-linker conjugates, including dedicated OEB-6 laboratory expansion mentioned for this work.

  • HPAPI development and manufacturing

    Development and handling of high-potency APIs with containment-supported R&D and manufacturing capabilities.

  • Flow chemistry

    Continuous-process development and scale-up from laboratory proof-of-concept through commercial manufacturing.

  • API manufacturing

    Manufacture of active pharmaceutical ingredients including generic APIs and anti-cancer APIs.

  • Intermediates manufacturing

    Manufacture of API intermediates, advanced intermediates, key starting materials, regulatory starting materials, and key building blocks.

  • Caffeine and xanthine derivatives

    Production of caffeine and xanthine derivatives for pharmaceutical and food/beverages applications.

8 more services
  • Acid & allied products
  • Process R&D and scale-up
  • HPAPIs
  • Route Scouting
  • Process R&D
  • Technology Transfer
  • Validation
  • Commercial Manufacturing

Capabilities

As they state on their website or in their listing.

Processes
  • Small molecule
  • Peptide
  • Oligonucleotide
  • Stability studies
Capacity
  • 450 KL/M³ manufacturing capacity at Atali
  • Approximately 31,200 litres reactor capacity at Dombivli
  • 100 MT per month caffeine capacity at Unit 5
  • 5,000 TPA xanthine capacity
  • 7 manufacturing units
  • 3 R&D centers
  • 100 MT per month caffeine production capacity at Unit 5
Scales
Ton

Equipment

  • Corning G5 Reactor
  • CorFlo Reactor
  • Corning G1 Reactor
  • Fixed Bed Reactor
  • MakSpeed Intenseflo Reactor
  • Plantrix® MR260
8 more
  • Agitated Thin Film Dryer
  • Agitated Thin Film Evaporator
  • Continuous Crystallizer
  • Falling Film Evaporator (FFE)
  • Spray Dryer
  • Flow reactors
  • Autoclaves
  • Fume hoods

Industries served

  • Pharmaceuticals
  • Nutraceuticals
  • Food and beverages
  • Biotechnology

Company

Type
CDMO
Founded
2022
Team
2400+ employees
Quality
ISO/IEC 27001:2022 · USFDA (Dombivli Unit; Tarapur Unit 4 mentioned as having inspection/approval) · EUGMP (Tarapur Unit 4 mentioned for audits/approval) · EDQM (Oncology block at Unit 4) · ANVISA (Tarapur Unit 4 audit completion mentioned) · EcoVadis Silver rating · SBTi approved emission reduction targets · Cofepris (Unit 4)

Locations

Based in
Mumbai, India
Sites
  • Navi Mumbai, India
  • Dombivli, India
  • Tarapur, India
  • Vapi, India
  • Atali, India
Serves
USA, European Union, Japan, regulated markets across the globe, global

Contacts

Public records

FDA drug establishment registration
3005256484 · API MANUFACTURE source

Similar labs